Process simulation based decisional tool to evaluate strategies for continuous downstream bioprocess implementation - A CDMO perspective
暂无分享,去创建一个
[1] Mark Pagkaliwangan,et al. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales , 2019, Biotechnology journal.
[2] Alex Xenopoulos,et al. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies. , 2015, Journal of biotechnology.
[3] Suzanne S Farid,et al. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture , 2017, Biotechnology progress.
[4] Gerhard Schembecker,et al. Cost evaluation of antibody production processes in different operation modes , 2016 .